Top 10 Key Players companies in Cardiogenic shock by Most Patent Filings in the United States in 2022 – Discovery

Free Trial

The Cardiogenic shock top 10 is Discovery PatSnap’ annual ranking of the top 10 Most Patent Filings Cardiogenic shock Key Players in the United States. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.

1	Procter & Gamble Co.	Ohio, United States	Toothpaste,Hair conditioner,SOAP, ...[+2]	Patent: 24
2	Eli Lilly & Co.	Indiana, United States	Medicine,Health care,Humalog Mix, ...[+2]	Patent: 7
3	ABIOMED, Inc.	Massachusetts, United States	Ventricular assist device,Medical equipment,Health care, ...[+2]	Patent: 7
4	Baxter International, Inc.	Illinois, United States	Clinical trial,Drug,Hemodialysis, ...[+2]	Patent: 6
5	Medtronic, Inc.	Minnesota, United States	Medicine,Implantable cardiac pacemaker,Biomedical engineering, ...[+2]	Patent: 1
6	Genentech, Inc.	California, United States	Biotechnology,Biology,Medicine, ...[+2]	Patent: 1
7	Sunovion Pharmaceuticals, Inc.	Massachusetts, United States	Medicine,Pharmacy and Therapeutics,Inhalation, ...[+2]	Patent: 1
8	STARTUP MyoKardia, Inc.	California, United States	Medicine,Pharmacy and Therapeutics,Cardiovascular agent, ...[+2]	Patent: 1
9	STARTUP iMFLUX, Inc.	Ohio, United States	Software	Patent: 1
10	PeriCor Therapeutics, Inc.	New York, United States	Medicine	Patent: 1